SIMVASTATIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 42 adverse event reports in the FDA FAERS database where SIMVASTATIN was used for Psoriasis.
Most Reported Side Effects for SIMVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 3,919 | 14.5% | 252 | 422 |
| Fatigue | 2,066 | 7.6% | 226 | 424 |
| Arthralgia | 1,775 | 6.6% | 221 | 318 |
| Drug interaction | 1,744 | 6.4% | 221 | 1,037 |
| Nausea | 1,676 | 6.2% | 481 | 635 |
| Rhabdomyolysis | 1,616 | 6.0% | 148 | 1,232 |
| Dyspnoea | 1,542 | 5.7% | 340 | 604 |
| Headache | 1,470 | 5.4% | 224 | 431 |
| Drug hypersensitivity | 1,433 | 5.3% | 125 | 171 |
| Muscular weakness | 1,356 | 5.0% | 19 | 362 |
| Malaise | 1,347 | 5.0% | 218 | 512 |
| Dizziness | 1,334 | 4.9% | 257 | 323 |
| Vomiting | 1,318 | 4.9% | 443 | 484 |
| Diarrhoea | 1,310 | 4.8% | 276 | 406 |
| Pain | 1,283 | 4.7% | 30 | 460 |
Other Indications for SIMVASTATIN
Product used for unknown indication (9,405)
Hypercholesterolaemia (3,010)
Blood cholesterol increased (2,592)
Hyperlipidaemia (1,320)
Dyslipidaemia (1,253)
Blood cholesterol (419)
Coronary artery disease (407)
Blood cholesterol abnormal (371)
Type iia hyperlipidaemia (294)
Low density lipoprotein increased (237)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)